FDA approves Aurobindo’s generic Nexium

SILVER SPRING, Md. — Aurobindo Pharma announced recently that it had received approval from the Food and Drug Administration for its generic Nexium (esomeprazole magnesium) delayed-release capsules. The drug is indicated to treat gastroesophageal reflux disease. 

 

Aurobindo’s generic will be available in 20- and 40-mg dosage strengths. The drug had an estimated market size of about $4.2 billion for the 12 months ending February 2016, according to IMS Health.